12.36 USD
+0.74 (+6.37%)
EMBC gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While EMBC has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on EMBC.
1. Profitability
1.1 Basic Checks
EMBC had positive earnings in the past year.
EMBC had a positive operating cash flow in the past year.
Each year in the past 5 years EMBC has been profitable.
Each year in the past 5 years EMBC had a positive operating cash flow.
1.2 Ratios
EMBC has a Return On Assets of 8.75%. This is amongst the best in the industry. EMBC outperforms 90.81% of its industry peers.
EMBC's Return On Invested Capital of 27.81% is amongst the best of the industry. EMBC outperforms 98.92% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EMBC is significantly above the industry average of 8.84%.
The 3 year average ROIC (22.63%) for EMBC is below the current ROIC(27.81%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.75% | ||
| ROE | N/A | ||
| ROIC | 27.81% |
ROA(3y)6.88%
ROA(5y)18.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)22.63%
ROIC(5y)31.94%
1.3 Margins
The Profit Margin of EMBC (8.83%) is better than 81.62% of its industry peers.
In the last couple of years the Profit Margin of EMBC has declined.
With an excellent Operating Margin value of 30.50%, EMBC belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
In the last couple of years the Operating Margin of EMBC has declined.
The Gross Margin of EMBC (63.85%) is better than 65.95% of its industry peers.
In the last couple of years the Gross Margin of EMBC has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.5% | ||
| PM (TTM) | 8.83% | ||
| GM | 63.85% |
OM growth 3Y-5.72%
OM growth 5Y-7.43%
PM growth 3Y-23.59%
PM growth 5Y-25.86%
GM growth 3Y-2.36%
GM growth 5Y-1.89%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EMBC is creating value.
EMBC has more shares outstanding than it did 1 year ago.
EMBC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EMBC is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.06 indicates that EMBC is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of EMBC (2.06) is better than 60.54% of its industry peers.
The Debt to FCF ratio of EMBC is 7.84, which is on the high side as it means it would take EMBC, 7.84 years of fcf income to pay off all of its debts.
EMBC has a better Debt to FCF ratio (7.84) than 74.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 7.84 | ||
| Altman-Z | 2.06 |
ROIC/WACC3.4
WACC8.18%
2.3 Liquidity
EMBC has a Current Ratio of 2.41. This indicates that EMBC is financially healthy and has no problem in meeting its short term obligations.
EMBC has a Current ratio of 2.41. This is comparable to the rest of the industry: EMBC outperforms 49.19% of its industry peers.
EMBC has a Quick Ratio of 1.73. This is a normal value and indicates that EMBC is financially healthy and should not expect problems in meeting its short term obligations.
EMBC has a Quick ratio of 1.73. This is comparable to the rest of the industry: EMBC outperforms 48.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.73 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 20.24% over the past year.
Measured over the past years, EMBC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -26.21% on average per year.
The Revenue has decreased by -3.80% in the past year.
Measured over the past years, EMBC shows a decrease in Revenue. The Revenue has been decreasing by -0.10% on average per year.
EPS 1Y (TTM)20.24%
EPS 3Y-25.33%
EPS 5Y-26.21%
EPS Q2Q%11.11%
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y-1.47%
Revenue growth 5Y-0.1%
Sales Q2Q%-7.72%
3.2 Future
The Earnings Per Share is expected to grow by 0.66% on average over the next years.
Based on estimates for the next years, EMBC will show a small growth in Revenue. The Revenue will grow by 1.59% on average per year.
EPS Next Y-0.06%
EPS Next 2Y0.71%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y0.05%
Revenue Next 3Y0.21%
Revenue Next 5Y1.59%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 4.16, the valuation of EMBC can be described as very cheap.
Based on the Price/Earnings ratio, EMBC is valued cheaply inside the industry as 98.92% of the companies are valued more expensively.
EMBC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.87.
EMBC is valuated cheaply with a Price/Forward Earnings ratio of 4.16.
100.00% of the companies in the same industry are more expensive than EMBC, based on the Price/Forward Earnings ratio.
EMBC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.16 | ||
| Fwd PE | 4.16 |
4.2 Price Multiples
98.38% of the companies in the same industry are more expensive than EMBC, based on the Enterprise Value to EBITDA ratio.
EMBC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. EMBC is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.96 | ||
| EV/EBITDA | 5.09 |
4.3 Compensation for Growth
The decent profitability rating of EMBC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.71%
EPS Next 3Y0.66%
5. Dividend
5.1 Amount
EMBC has a Yearly Dividend Yield of 5.05%, which is a nice return.
EMBC's Dividend Yield is rather good when compared to the industry average which is at 0.20. EMBC pays more dividend than 99.46% of the companies in the same industry.
EMBC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.05% |
5.2 History
EMBC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
EMBC pays out 36.69% of its income as dividend. This is a sustainable payout ratio.
DP36.69%
EPS Next 2Y0.71%
EPS Next 3Y0.66%
NASDAQ:EMBC (1/6/2026, 3:51:07 PM)
12.36
+0.74 (+6.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners99.49%
Inst Owner Change0%
Ins Owners1.29%
Ins Owner Change28.53%
Market Cap723.18M
Revenue(TTM)1.08B
Net Income(TTM)95.40M
Analysts51.11
Price Target17 (37.54%)
Short Float %5.84%
Short Ratio5.72
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.05% |
Yearly Dividend0.6
Dividend Growth(5Y)N/A
DP36.69%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.51%
Min EPS beat(2)-8.66%
Max EPS beat(2)41.68%
EPS beat(4)3
Avg EPS beat(4)26.75%
Min EPS beat(4)-8.66%
Max EPS beat(4)44.01%
EPS beat(8)7
Avg EPS beat(8)35.11%
EPS beat(12)9
Avg EPS beat(12)26.08%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.77%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)4.13%
Revenue beat(4)2
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)4.13%
Revenue beat(8)5
Avg Revenue beat(8)1.57%
Revenue beat(12)9
Avg Revenue beat(12)1.87%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.96%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.47%
Revenue NQ rev (1m)-1.15%
Revenue NQ rev (3m)-2.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.16 | ||
| Fwd PE | 4.16 | ||
| P/S | 0.67 | ||
| P/FCF | 3.96 | ||
| P/OCF | 3.77 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.09 |
EPS(TTM)2.97
EY24.03%
EPS(NY)2.97
Fwd EY24.01%
FCF(TTM)3.12
FCFY25.22%
OCF(TTM)3.28
OCFY26.51%
SpS18.47
BVpS-11.12
TBVpS-11.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.75% | ||
| ROE | N/A | ||
| ROCE | 39.73% | ||
| ROIC | 27.81% | ||
| ROICexc | 38.19% | ||
| ROICexgc | 39.66% | ||
| OM | 30.5% | ||
| PM (TTM) | 8.83% | ||
| GM | 63.85% | ||
| FCFM | 16.88% |
ROA(3y)6.88%
ROA(5y)18.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)22.63%
ROIC(5y)31.94%
ROICexc(3y)32.83%
ROICexc(5y)43.39%
ROICexgc(3y)34.19%
ROICexgc(5y)45.56%
ROCE(3y)32.33%
ROCE(5y)45.63%
ROICexgc growth 3Y-16%
ROICexgc growth 5Y-7.86%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y-7.62%
OM growth 3Y-5.72%
OM growth 5Y-7.43%
PM growth 3Y-23.59%
PM growth 5Y-25.86%
GM growth 3Y-2.36%
GM growth 5Y-1.89%
F-Score6
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 7.84 | ||
| Debt/EBITDA | 3.83 | ||
| Cap/Depr | 22.85% | ||
| Cap/Sales | 0.86% | ||
| Interest Coverage | 3.17 | ||
| Cash Conversion | 51.78% | ||
| Profit Quality | 191.2% | ||
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.73 | ||
| Altman-Z | 2.06 |
F-Score6
WACC8.18%
ROIC/WACC3.4
Cap/Depr(3y)49.26%
Cap/Depr(5y)65.23%
Cap/Sales(3y)1.54%
Cap/Sales(5y)2.02%
Profit Quality(3y)91.71%
Profit Quality(5y)109.85%
High Growth Momentum
Growth
EPS 1Y (TTM)20.24%
EPS 3Y-25.33%
EPS 5Y-26.21%
EPS Q2Q%11.11%
EPS Next Y-0.06%
EPS Next 2Y0.71%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y-1.47%
Revenue growth 5Y-0.1%
Sales Q2Q%-7.72%
Revenue Next Year0%
Revenue Next 2Y0.05%
Revenue Next 3Y0.21%
Revenue Next 5Y1.59%
EBIT growth 1Y47.56%
EBIT growth 3Y-7.11%
EBIT growth 5Y-7.53%
EBIT Next Year15.9%
EBIT Next 3Y4.95%
EBIT Next 5YN/A
FCF growth 1Y816.58%
FCF growth 3Y-22.26%
FCF growth 5Y-16.78%
OCF growth 1Y436.98%
OCF growth 3Y-22.52%
OCF growth 5Y-17.41%
EMBECTA CORP / EMBC FAQ
What is the fundamental rating for EMBC stock?
ChartMill assigns a fundamental rating of 6 / 10 to EMBC.
What is the valuation status for EMBC stock?
ChartMill assigns a valuation rating of 8 / 10 to EMBECTA CORP (EMBC). This can be considered as Undervalued.
Can you provide the profitability details for EMBECTA CORP?
EMBECTA CORP (EMBC) has a profitability rating of 7 / 10.
What are the PE and PB ratios of EMBECTA CORP (EMBC) stock?
The Price/Earnings (PE) ratio for EMBECTA CORP (EMBC) is 4.16 and the Price/Book (PB) ratio is -1.11.
Can you provide the expected EPS growth for EMBC stock?
The Earnings per Share (EPS) of EMBECTA CORP (EMBC) is expected to decline by -0.06% in the next year.